What is inflammatory diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Inflammatory Diarrhea

Inflammatory diarrhea is characterized by liquid loose stools with blood or mucous discharge, resulting from colonic or intestinal inflammation that damages the mucosa and triggers an acute inflammatory response with cytokine activation. 1

Pathophysiologic Mechanism

Inflammatory diarrhea occurs through two primary pathways:

  • Cytotoxin-producing, noninvasive bacteria (e.g., enterohemorrhagic E. coli, C. difficile) adhere to the mucosa, activate cytokines, and stimulate the intestinal mucosa to release inflammatory mediators without direct invasion 2

  • Invasive organisms (e.g., Salmonella, Shigella, Campylobacter, Entamoeba histolytica) invade the intestinal mucosa to induce acute inflammatory reaction, involving cytokine activation and inflammatory mediator release 2

  • In inflammatory bowel disease (IBD), chronic intestinal inflammation originates from an overly aggressive mucosal immune response against luminal bacteria in genetically susceptible individuals 1

Clinical Characteristics That Distinguish Inflammatory from Other Diarrheas

Key distinguishing features include:

  • Stool appearance: Liquid loose stools containing visible blood or mucous, contrasting with the bulky, malodorous pale stools of malabsorption 1

  • Increased stool frequency with urgency and tenesmus, particularly in ulcerative colitis where mucosal inflammation starts distally in the rectum 3

  • Rectal bleeding occurs commonly, especially in ulcerative colitis 3

  • Systemic symptoms: Abdominal pain, fever, weight loss, and signs of systemic inflammation 4, 5

Diagnostic Approach

Laboratory markers:

  • Fecal calprotectin >100-250 μg/g indicates active intestinal inflammation with 93% sensitivity and 96% specificity for IBD 3

  • Elevated inflammatory markers (ESR, CRP) and anemia suggest inflammatory etiology 6

  • Important caveat: Fecal leukocyte examination and stool lactoferrin should NOT be used to establish the cause of acute infectious diarrhea due to poor performance, intermittent presence, and degradation during transport 1

Endoscopic evaluation:

  • Flexible sigmoidoscopy with biopsies is essential to confirm diagnosis and assess disease severity in suspected colonic inflammatory diarrhea 6

  • Colonoscopy with biopsies remains the gold standard for diagnosing ulcerative colitis and other inflammatory bowel diseases 6, 4

Common Causes

Infectious causes:

  • Bacterial pathogens including C. difficile, particularly with recent antibiotic exposure 7
  • Cytomegalovirus (CMV) in immunocompromised patients or those with underlying IBD 7

Inflammatory bowel disease:

  • Ulcerative colitis presents with continuous inflammation limited to the colon with rectal involvement 7
  • Crohn's disease shows patchy, transmural inflammation affecting any part of the gastrointestinal tract 7

Other causes:

  • Ischemic colitis in older adults with vascular disease 7
  • Medication-induced colitis (NSAIDs, antibiotics) 7
  • Radiation colitis following pelvic radiotherapy 7

Critical Clinical Pitfalls

  • Always exclude infectious causes first, particularly C. difficile, before attributing symptoms to IBD flare, as infection can mimic or coexist with IBD 6

  • Not all colitis presents with bloody diarrhea—microscopic colitis typically presents with watery, non-bloody diarrhea despite being inflammatory in nature 7

  • Do not perform full colonoscopy in acute severe colitis due to perforation risk; flexible sigmoidoscopy is adequate 6

  • Antidiarrheal agents like loperamide are contraindicated in extremely ill patients with evidence of obstruction, colonic dilation, fever, or abdominal tenderness 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mechanisms of infectious diarrhea.

Nature clinical practice. Gastroenterology & hepatology, 2008

Guideline

Stool Findings in Inflammatory Bowel Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Inflammatory bowel disease: clinical aspects and treatments.

Journal of inflammation research, 2014

Guideline

Ulcerative Colitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colitis Causes and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What symptom is most correlated with the severity of inflammatory bowel disease?
What is the treatment approach for inflammatory diarrhea?
What is the treatment approach for inflammatory bowel disease (IBD)?
What is the recommended diagnostic approach for a patient presenting with symptoms of an inflammatory process in the gastrointestinal tract, such as diarrhea, abdominal pain, or weight loss?
What symptom is most closely related to the severity of inflammatory bowel disease?
Is N-acetylcysteine (NAC) indicated in all cases of severe transaminitis with levels over 1000, regardless of the cause?
What is the recommended vitamin D and calcium supplementation regimen for elderly patients or those with a history of osteoporosis or kidney disease?
What is the recommended antibiotic dosing for a 3-year-old patient with group A streptococcal (GAS) pharyngitis and no known allergies or underlying medical conditions?
Is it appropriate to continue rosuvastatin 20 mg for cholesterol management in a patient with hypertension, smoking history, and recent cardiac test abnormalities, and when should the lipid panel be rechecked?
What is the best treatment approach for a patient with intertrigo of the genitocrural region complicated by Candida, considering potential underlying conditions such as diabetes or obesity?
What is the differential diagnosis and management plan for a patient with severe anemia, Chronic Myeloid Leukemia (CML) in blast phase, gouty arthritis, and grade 2 pitting bipedal edema, with consideration of lab work including complete blood count, renal function, liver function tests, echocardiography, and uric acid level?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.